Crossmark

Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD

Crossref DOI link: https://doi.org/10.1038/bmt.2016.63

Published Online: 2016-04-11

Published Print: 2016-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

He, F

Warlick, E

Miller, J S

MacMillan, M

Verneris, M R

Cao, Q

Weisdorf, D
License Information

Text and Data Mining valid from 2016-04-11

Version of Record valid from 2016-04-11
More Information

Article History

Received: 23 July 2015

Revised: 4 February 2016

Accepted: 6 February 2016

First Online: 11 April 2016

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below